Latest Articles

  • A 55-year-old man with idiopathic recurrent pancreatitis
    J. Brad Morrow, MD and Darwin L. Conwell, MD
    Cleveland Clinic Journal of Medicine February 1999, 66 (2) 84-86;

    What is the likely cause of this patient’s symptoms? A self-test on a clinical case.

  • Issues and controversies in venous thromboembolism
    Teresa L. Carman, MD and Bernardo B. Fernandez, MD, FACP
    Cleveland Clinic Journal of Medicine February 1999, 66 (2) 113-123;

    Discussions and recommendations on nine issues in thromboembolism, not commonly addressed in most reviews.

  • Is stress linked to heart disease?
    Fredric J. Pashkow, MD
    Cleveland Clinic Journal of Medicine February 1999, 66 (2) 75-77;

    Recent evidence confirms the popular folklore that mental stress has harmful effects on coronary health. Stress management programs are beneficial in coronary rehabilitation.

  • The Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Study
    Vasant B. Patel, MD and David J. Moliterno, MD
    Cleveland Clinic Journal of Medicine February 1999, 66 (2) 100-104;

    Angiography still has a role in non-Q-wave MI, study results notwithstanding.

  • New technology and new challenges for assisted reproduction
    Tommaso Falcone, MD
    Cleveland Clinic Journal of Medicine February 1999, 66 (2) 78-82;

    With advances in the science of reproduction come more options, and more ethical dilemmas.

  • The Hypertension Optimal Treatment Trial
    Donald G. Vidt, MD and Marc A. Pohl, MD
    Cleveland Clinic Journal of Medicine February 1999, 66 (2) 105-111;

    In hypertensive patients, low-dose aspirin proves beneficial, but more-aggressive blood pressure treatment falls short—except in persons with diabetes.

  • In Response: Prostate cancer screening (October 1998)
    Kenneth W. Vaughn, MD
    Cleveland Clinic Journal of Medicine February 1999, 66 (2) 125;
  • Zinc lozenges for the common cold
    Michael L. Macknin, MD
    Cleveland Clinic Journal of Medicine January 1999, 66 (1) 27-32;

    Clinical trials of zinc cold therapy have produced conflicting results.

  • The Breast Cancer Prevention Trial (P-1 Study)
    Beth A. Overmoyer, MD
    Cleveland Clinic Journal of Medicine January 1999, 66 (1) 33-40;

    Tamoxifen can reduce the incidence of breast cancer by nearly half in women at high risk, but at the price of increased endometrial cancer and thromboembolism. An illustration shows the differing effects of tamoxifen in different organs.

  • Dear Colleague
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine January 1999, 66 (1) 7;

Pages